Weekly vs. Every-3-Week Paclitaxel and Carboplatin for Ovarian Cancer

Overview of attention for article published in New England Journal of Medicine, February 2016

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (99th percentile)
Good Attention Score compared to outputs of the same age and source (73rd percentile)

Mentioned by

news: 20 news outlets
blogs: 1 blog
policy: 2 policy sources
twitter: 55 X users

facebook: 2 Facebook pages
wikipedia: 1 Wikipedia page
googleplus: 2 Google+ users
guideline: 8 clinical guideline sources

Readers on

mendeley: 323 Mendeley

So far, Altmetric has seen 25 news stories from 20 outlets.

Clinical Overview: The Addition of Curcumin to Standard Ovarian Cancer Chemotherapy

Pharmacy Times, 21 Mar 2023

Introduction Ovarian cancer is the second most common gynecological cancer among American women, accounting for the most cancer-r…

Aggressive surgery for advanced ovarian cancer decreases the risk of intraperitoneal recurrence

Medical Health News, 05 Jun 2020

1. Chi DS, Eisenhauer EL, Lang J et al (2006) What is the optimal goal of primary cytoreductive surgery for bulky stage IIIC…

2016 in Oncology with Dr Bishal Gyawali. ecancer

ecancer, 22 Dec 2016

Independent blogger Dr Bishal Gyawali rounds up 2016's publications in oncology 2016 was an important year for me, as I started…

UAB clinical trial study finds ovarian cancer survival rates did not rise with increased paclitaxel

Noodls, 04 Mar 2016

The University of Alabama at Birmingham (via noodls) / Re study conducted at UAB shows that weekly dosage of paclitaxel versus…

This page shows the most recent news stories that mention this research output. Click here to find out how to access more activity, including 21 additional news stories.